Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Bactolife A/S
A/S
Active
Reklamebeskyttelse
CVR 38879073
Rønnegade 8, 2100
København Ø
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 2017 · 8 years old
52 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Bactolife A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
CS
Claus Sebastian Søderberg
Chief Executive Officer
Chief Executive Officer
2023
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (7)
MA
Mads Aage Laustsen
Board of Directors
Board of Directors
2023
SS
Sara Sande
Board of Directors
Board of Directors
2025
SA
Sophia Andrea Helga Heyde
Board of Directors
Board of Directors
2025
FJ
Frank Julian Zachmann
Board of Directors
Board of Directors
2023
RD
Rhonda Doyce Hoffman
Board of Directors
Board of Directors
2023
JR
Jørgen Rugholm Jensen
Chairman
Chairman
2021
DM
Donna Margaret Parr
Board of Directors
Board of Directors
2025
Former (4)
MJ
Morten Jensen
Board of Directors
Board of Directors
2021 – 2021
MA
Morten Aleksandr Engel
Board of Directors
Board of Directors
2021 – 2025
PF
Per Falholt
Board of Directors
Board of Directors
2017 – 2023
AH
Andreas Hougaard Laustsen-Kiel
Board of Directors
Board of Directors
2017 – 2021
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
20–24.99%
20–24.99%
2025
ATHOS Biopharma GmbH
Individual
20–24.99%
20–24.99%
2025
Gates Foundation
Individual
10–14.99%
10–14.99%
2026
Danmarks Eksport- og Investeringsfond
Company
5–9.99%
5–9.99%
2025
SELFINVEST ApS
Company
5–9.99%
5–9.99%
2025
MR BIOINVEST ApS
Company
5–9.99%
5–9.99%
2025
EEP CO-Investment Ltd.
Individual
5–9.99%
5–9.99%
2021
LILLE FREDERIKSLUND INVEST ApS
Company
5–9.99%
5–9.99%
2023
NOVOZYMES A/S
Company
5–9.99%
5–9.99%
2023
David Carl Christian von Kauffmann
Individual
10–14.99%
10–14.99%
2018
Sandra Wingaard Thrane
Individual
5–9.99%
5–9.99%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Bactolife A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network